|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Re-engineering solution to enhance the performance and delivery of drug formulations. |
 |
| Management |
| Pascal Hickey, Chief Operating Officer; Neil Foster, Ph.D., Technical Director; Hubert Regtop, Research Director |
| |
|
|
|
|
|
|
|
| Keywords |
| drug delivery, solubility, pharmaceuticals, proteins, peptides, Supercritical Fluid, DrugDelivery |
|
|
|
| Description |
|
Eiffel Technologies works to improve the the solubility and bioavailability of pharmaceuticals, proteins and peptides. |
 |
| Products / Services |
Re-engineering solution to enhance the performance and delivery of drug formulations with wide-ranging physicochemical properties.
|
 |
| Technology / Differentiation |
| Supercritical Fluid technologies can be used to produce uniform, very small drug particles. Drugs produced in this way have the potential to be delivered in more convenient and effective dose forms. |
 |
 |
|
|
|
|
|
|